The story of Viagra presents a intricate picture for investors. While the initial launch generated substantial returns, the lapse of its intellectual property protection opened the avenue to off-brand versions, https://bookmarkja.com/story24491008/the-copyright-and-the-pharmaceutical-industry-a-risky-bet